proNGF Measurement in Cerebrospinal Fluid Samples of a Large Cohort of Living Patients With Alzheimer's Disease by a New Automated Immunoassay

proNGF Measurement in Cerebrospinal Fluid Samples of a Large Cohort of Living Patients With Alzheimer's Disease by a New Automated Immunoassay

The discovery of new biomarkers for Alzheimer's disease (AD) is essential for an accurate diagnosis, to conceive new strategies of treatments, and for monitoring the efficacy of potential disease-modifying therapies in clinical trials. proNGF levels in the cerebrospinal fluid (CSF) represent a...

Full description

Bibliographic Details
Main Authors: Francesca Malerba, Ivan Arisi, Rita Florio, Chiara Zecca, Maria Teresa Dell'Abate, Bruno Bruni Ercole, Serena Camerini, Marialuisa Casella, Giancarlo Logroscino, Antonino Cattaneo
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Aging Neuroscience
Subjects:
Alzheimer's disease
proNGF
immunoassay
biomarker
diagnosis
neurodegenerative diseases
Online Access:https://www.frontiersin.org/articles/10.3389/fnagi.2021.741414/full

Internet

https://www.frontiersin.org/articles/10.3389/fnagi.2021.741414/full

Similar Items